Literature DB >> 12239926

Endoscopic findings of bleeding esophagogastric varices.

Hiroshi Yoshida1, Masahiko Onda, Takashi Tajiri, Yasuhiro Mamada, Nobuhiko Taniai.   

Abstract

BACKGROUND/AIMS: Endoscopic findings of bleeding gastric and esophageal varices were compared.
METHODOLOGY: Seventy patients with first bleeding esophagogastric varices without prior treatments were treated: 47 patients had bleeding esophageal varices (EV group), 11 patients had bleeding cardiac varices (CV group), and 12 patients had bleeding cardiofundic or fundic varices (FV group).
RESULTS: The red color sign was more common in the EV group (45 patients) than in the CV group (4 patients) or FV group (no patients) (P < 0.0001); Mucosal erosion over the varices at the site of bleeding was more common in the CV group (9 patients, P < 0.0005) and FV group (12 patients, P < 0.0001) than in the EV group (12 patients). An ulcer at the bleeding point was more common in the CV group (7 patients, P < 0.01) and FV group (10 patients, P < 0.0001) than in the EV group (11 patients). Gastric ulcer was more common in the CV group (7 patients, P < 0.05) and FV group (10 patients, P < 0.001) than in the EV group (14 patients). Erosive gastritis was more frequent in the FV group (12 patients, P < 0.02) than in the EV group (30 patients).
CONCLUSIONS: Violation of the mucosa barrier overlying gastric varices, especially cardiofundic or fundic varices, might be an important step leading to variceal hemorrhage.

Entities:  

Mesh:

Year:  2002        PMID: 12239926

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

Review 1.  New methods for the management of gastric varices.

Authors:  Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Takashi Tajiri
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 2.  New methods for the management of esophageal varices.

Authors:  Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Takashi Tajiri
Journal:  World J Gastroenterol       Date:  2007-03-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.